Eastgate Biotech Corp.
ETBI
$0.00
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Net Income | -234.33% | -51.63% | 34.94% | 31.06% | 43.37% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3,189.47% | -- | -29.96% | 111.68% | -98.87% |
| Change in Net Operating Assets | -64.35% | -- | -58.81% | -77.78% | 125.03% |
| Cash from Operations | -470.20% | 72.21% | -17.39% | -817.93% | 399.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1,309.42% | -- | 50.90% | 437.66% | -13.76% |
| Total Debt Repaid | -1,118.57% | -- | -- | -283.33% | -70.73% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,249.07% | -- | 54.18% | 186.94% | -20.16% |
| Foreign Exchange rate Adjustments | -100.00% | -- | -470.00% | 710.29% | 380.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -116.00% | 114.68% | 210.71% | -100.00% | -- |